;where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed."/>
公开/公告号US2020308181A1
专利类型
公开/公告日2020-10-01
原文格式PDF
申请/专利权人 CELTAXSYS INC.;
申请/专利号US202016738190
发明设计人 DAMIAN O. ARNAIZ;GREG BROWN;EMMANUEL CLARET;ARWED CLEVE;DAVID DAVEY;WILLIAM GUILFORD;SEOCK-KYU KHIM;THOMAS KIRKLAND;MONICA J. KOCHANNY;AMY LIANG;DAVID LIGHT;JOHN PARKINSON;GUO PING WEI;BIN YE;
申请日2020-01-09
分类号C07D487/08;C07C217/58;C07C229/38;C07C233/78;C07C255/57;C07C271/20;C07D207/04;C07D211/58;C07D243/08;C07D295/04;C07D295/16;C07D451/04;C07D207/09;C07D211/26;C07D263/32;C07D295/096;C07D401/10;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07C229/08;C07D263/14;C07D401/12;C07D207/16;C07D211/34;C07D277/22;C07D277/68;C07D451/02;
国家 US
入库时间 2022-08-21 11:23:11